Physician profile
Daniela M Buzzetta
NPI 1992278782
$1,645.06
in general payments reported to CMS, 2019-2025
12 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.26 · 2022: $638 · 2023: $394 · 2024: $328 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $700.96 | 2022-2025 | Mako |
| Depuy Synthes Sales INC. | $233.40 | 2023-2024 | Orthovisc |
| Dermavant Sciences, INC. | $195.00 | 2024 | Vtama |
| Axogen | $168.75 | 2022 | |
| Ethicon US, LLC | $137.53 | 2022 | |
| Biocryst US Sales Co., LLC | $80.00 | 2023 | Orladeyo |
| Horizon Therapeutics Plc | $29.96 | 2021-2022 | |
| Baxter Healthcare | $27.24 | 2025 | Tisseel |
| Pacira Pharmaceuticals Incorporated | $24.73 | 2023 | Iovera |
| Convatec INC. | $18.54 | 2021 | |
| Abbott Laboratories | $15.43 | 2024 | Infinity |
| Kci USA, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Buzzetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.